Moreover, in log2 (TPM+1) normalized profiles, we found that SETD2 was positively associated with the expression of more genes (Figure 5D), especially in tumor cells (positive rate: 78.7%) and myeloid cells (positive rate: 73.7%), while the opposite was observed in mast cells (positive rate: 46.4%) and epithelial cells (positive rate: 44.1%). The gene discussed is SETD2; the disease is neoplasm.